The Latest Cardiac and Vascular News
CARLSBAD, Calif. and BRISBANE, Australia, Sept. 30, 2022 /PRNewswire/ — ImpediMed Limited (ASX: IPD), a global medical technology company using bioimpedance spectroscopy (BIS) to generate powerful data to maximize patient health, today announced two poster presentations at the Heart Failure Society of America (HFSA) Annual Scientific Meeting, which is taking place Sept. 30 to Oct. […]
— Pediatric efficacy data for both patients show initial improvements across clinical, functional and biomarker endpoints with six to nine months of follow-up; positive results including protein expression obtained at three and six months consistent with adult cohorts at similar timeframe— — Results demonstrate sustained clinical benefit across all parameters in adult […]
ROCKVILLE, Md. , May 17, 2022 /PRNewswire/ — A new position paper published today by the Heart Failure Society of America (HFSA) outlines disparities in healthcare that affect patients with heart failure, including race and ethnicity, socioeconomic factors, and social determinants of health. The statement also presents actions that can be taken to […]
PHILADELPHIA–(BUSINESS WIRE)–Renovacor, Inc. (NYSE: RCOR), a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases, today announced partnerships with the Dilated Cardiomyopathy (DCM) Foundation, the Heart Failure Society of America (HFSA) and the American Association of Heart […]
ROCKVILLE, Md., Jan. 28, 2019 /PRNewswire/ — The Heart Failure Society of America (HFSA) has announced that John D. Barnes has been chosen by the Board of Directors as the society’s new Chief Executive Officer. As CEO, he will oversee the implementation of the society’s vision, mission, and strategic plan and assume day-to-day leadership of […]
